Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Peringkat dalam Saham #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Harga Saham
$38.41
Kapitalisasi Pasar
$170.67B
Perubahan (1 hari)
1.17%
Perubahan (1 tahun)
-49.92%
Negara
DK
Perdagangan Novo Nordisk A/S (NVO)

Kategori

Jumlah saham beredar untuk Novo Nordisk A/S (NVO)
Jumlah saham beredar per December 2025: 4.44B
Menurut laporan keuangan terbaru dan harga saham Novo Nordisk A/S, jumlah saham beredar saat ini adalah 4.44B. Pada akhir March 2026, perusahaan memiliki 0 saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Novo Nordisk A/S (NVO) dari 2026 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
253.90M -94.29%
US
102.90M -97.68%
US
190.00M -95.72%
BE
483.58M -89.12%
AU
61.42M -98.62%
NL